CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
The RNA-binding protein Tristetraprolin (TTP, ZFP36) functions as a tumor suppressor that impairs the development and disables the maintenance of MYC-driven lymphoma. In addition, other human cancers expressed reduced levels of TTP, suggesting that it may function as a tumor suppressor in several ma...
Main Authors: | Mohammad Fallahi, Antonio L Amelio, John L Cleveland, Robert J Rounbehler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4277357?pdf=render |
Similar Items
-
Roles of Tristetraprolin in Tumorigenesis
by: Jeong-Min Park, et al.
Published: (2018-10-01) -
The ARE-binding protein Tristetraprolin (TTP) is a novel target and mediator of calcineurin tumor suppressing function in the skin.
by: Xunwei Wu, et al.
Published: (2018-05-01) -
Role of Tristetraprolin in the Resolution of Inflammation
by: Peter Rappl, et al.
Published: (2021-01-01) -
Targeting MYCN in Molecularly Defined Malignant Brain Tumors
by: Anna Borgenvik, et al.
Published: (2021-01-01) -
Tristetraprolin, a Potential Safeguard Against Carcinoma: Role in the Tumor Microenvironment
by: Diwen Zhang, et al.
Published: (2021-05-01)